PubRank

Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients (FENSY)

Clinical Trial ID NCT02544685

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02544685

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995 13.30
2 Probiotics in man and animals. J Appl Bacteriol 1989 7.43
3 Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004 3.64
4 Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005 3.02
5 Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003 2.70
6 A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991 2.30
7 Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995 2.08
8 Probiotic bacteria: safety, functional and technological properties. J Biotechnol 2000 2.05
9 The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 1996 2.03
10 Demonstration of safety of probiotics -- a review. Int J Food Microbiol 1998 2.02
11 Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother 1990 1.93
12 Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006 1.86
13 Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 1998 1.78
14 Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003 1.72
15 Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 2002 1.69
16 Antibiotic resistance in food lactic acid bacteria--a review. Int J Food Microbiol 2005 1.69
17 Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999 1.64
18 Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002 1.57
19 Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. Plasmid 1994 1.56
20 Immune system stimulation by probiotics. J Dairy Sci 1995 1.44
21 Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J Bacteriol 1994 1.39
22 Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Prot 1998 1.23
23 Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 2002 1.18
24 Molecular characterization of tet(M) genes in Lactobacillus isolates from different types of fermented dry sausage. Appl Environ Microbiol 2003 1.18
25 Safety of probiotics: comparison of two popular strains. BMJ 2006 1.16
26 Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clin Diagn Lab Immunol 2003 1.14
27 Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance. Plasmid 1997 1.13
28 Probiotics and immune response. Am J Gastroenterol 2000 1.10
29 Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep) 2011 1.08
30 Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis 1996 1.07
31 Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol 1998 1.04
32 Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004 1.02
33 Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1998 1.00
34 The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol 2014 0.99
35 Lactobacillus species as emerging pathogens in neutropenic patients. Eur J Clin Microbiol Infect Dis 1997 0.99
36 Probiotics in the United States. Clin Infect Dis 2008 0.98
37 Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect 1996 0.96
38 Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2011 0.94
39 Gastrointestinal flora and its alterations in critical illness. Curr Opin Clin Nutr Metab Care 1999 0.94
40 Stimulation of cytokine production in clonal macrophage and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. J Food Prot 1998 0.93
41 Mobilization and location of the genetic determinant of chloramphenicol resistance from Lactobacillus plantarum caTC2R. Plasmid 1992 0.91
42 Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res 2013 0.90
43 Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis 2004 0.89
44 [Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS]. Ann Med Interne (Paris) 1991 0.89
45 Probiotic Lactobacillus strains protect against myelosuppression and immunosuppression in cyclophosphamide-treated mice. Int Immunopharmacol 2014 0.87
46 In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli. Infect Immun 1999 0.87
47 Streptococcus lactis septicemia in a patient with chronic lymphocytic leukemia. Am J Hematol 1995 0.85
48 Prophylactic effect of Enterococcus faecalis FK-23 preparation on experimental candidiasis in mice. Microbiol Immunol 1996 0.83
49 Monoassociation with Lactobacillus acidophilus UFV-H2b20 stimulates the immune defense mechanisms of germfree mice. Braz J Med Biol Res 1998 0.82
50 Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 1998 0.80
51 Saccharomyces cerevisiae fungemia with granulomas in the bone marrow in a patient undergoing BMT. Bone Marrow Transplant 1995 0.79
52 Potential of goat probiotic to bind mutagens. Anaerobe 2014 0.79
53 Bifidobacteria and human health: regulatory effect of indigenous bifidobacteria on Escherichia coli intestinal colonization. Anaerobe 2006 0.78
54 [The Saccharomyces boulardii therapy of HIV-associated diarrhea]. Dtsch Med Wochenschr 1993 0.76
55 A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients. Diagn Microbiol Infect Dis 1990 0.75
56 Effect of orally administered heat-killed Enterococcus Faecalis FK-23 preparation on neutropenia in dogs treated with cyclophosphamide. Int J Immunopharmacol 1996 0.75
57 Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Neoplasma 2005 0.75
58 Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part I. Bacteria. Clin Microbiol Infect 1999 0.75
59 Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support Care Cancer 2005 0.75
60 Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement Ther Med 2013 0.75
Next 100